Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease

Chronic kidney disease (CKD) will progress to end stage without treatment, the decline off renal function may not linear. A sensitive marker such as soluble urokinase-type plasminogen activator receptors (suPARs) may allow potential intervention and treatment in earlier stages of CKD. OBJECTIVES: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Reem M., Khalil, Mona A., Ibrahim, Amal H., Eid, Hanaa M., Abdelbasset, Walid Kamal, Soliman, Gaber S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756685/
https://www.ncbi.nlm.nih.gov/pubmed/31567954
http://dx.doi.org/10.1097/MD.0000000000017146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756685/
https://www.ncbi.nlm.nih.gov/pubmed/31567954
http://dx.doi.org/10.1097/MD.0000000000017146

Ejemplares similares